Blueprint Medicines(us:BPMC)

    90.46

    +0.14%

    Updated on 2024-12-25

    Open:90.77
    Close:90.46
    High:90.77
    Low:89.22
    Pre Close:90.33
    Volume:113597.00
    Amount:10.26M
    Turnover:0.18%
    Shares:63.53M
    MarketCap:5.75B

    About Blueprint Medicines Company

    Blueprint Medicines Corp. is a precision therapy company, which engages in the invention of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.

    Company Name: Blueprint Medicines
    Company Address: 45 Sidney Street
    Employees: 655
    Fiscar Year: 12-31
    IPO Date: 2015-04-30
    CIK: 1597264

    View all SEC Filings

    About

    Blueprint Medicines Corp. is a precision therapy company, which engages in the invention of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.
    Address:45 Sidney Street
    Website:http://www.blueprintmedicines.com

    Market Movers